Insight

Biagio Ricciuti: Comprehensive mutational scanning of EGFR reveals TKI sensitivities of extracellular domain mutants

Photo taken from Nature Communications

May 11, 2024, 12:13

Biagio Ricciuti: Comprehensive mutational scanning of EGFR reveals TKI sensitivities of extracellular domain mutants

Biagio Ricciuti, Medical Oncologist at Dana-Farber Cancer Institute, shared on X/Twitter:

“Comprehensive mutational scanning of EGFR reveals TKI sensitivities of extracellular domain mutants.

Multiple EGFR extracellular domain variants not associated with approved targeted therapies were sensitive to afatinib and dacomitinib in vitro
Two patients with glioblastoma with somatic EGFR G598V dimerization domain mutations showed responses to dacomitinib”

Read the article.
Source: Biagio Ricciuti/X
OncoDaily

Afatinib Biagio Ricciuti cancer cancer treatment Dacomitinib EGFR Mutations Extracellular Domain Variants glioblastoma Mutation Scanning OncoDaily Oncology oncology research Research Somatic Mutations targeted therapies TKI Sensitivities

Oncologist Near Me - Vivek Subbiah: Pionner of Precision Oncology

Monica Bertagnolli is ending her tenure as NIH director

NEW PAPER ALERT: Efficacy of CDK4/6 Inhibitors and Endocrine Therapy in HR+/HER2- Advanced Breast Cancer by PAM50 Subtype: SOLTI-1801 CDK-PREDICT Results

Oncologist Near Me – Fabrice André: Leading Expert in Breast Cancer

Funding Impactful Cancer Research That Might Otherwise Go Unsupported: Ryan Schoenfeld on the Secret Behind Mark Foundation’s Success